Seres Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Seres Therapeutics, Inc. (MCRB) had Deferred Tax Assets, Operating Loss Carryforwards of $167.20 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $167.20M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $156.16M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $142.51M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $132.56M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $167.20M 10-K · filed 2026-03-12 |
| 2024-12-31 | $156.16M 10-K · filed 2026-03-12 |
| 2023-12-31 | $142.51M 10-K · filed 2025-03-13 |
| 2022-12-31 | $132.56M 8-K · filed 2024-08-15 |
| 2021-12-31 | $108.19M 10-K · filed 2023-03-07 |
| 2020-12-31 | $106.35M 10-K · filed 2022-03-01 |
| 2019-12-31 | $72.75M 10-K · filed 2021-03-02 |
| 2018-12-31 | $50.72M 10-K · filed 2020-03-02 |
| 2017-12-31 | $33.00M 10-K · filed 2019-03-06 |
| 2016-12-31 | $18.48M 10-K · filed 2018-03-08 |
| 2015-12-31 | $25.29M 10-K · filed 2017-03-16 |
| 2014-12-31 | $7.95M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |